TVTX: Travere Therapeutics, Inc. Company Aggregate Debts

Symbol and logo of brand Travere Therapeutics Inc (TVTX)

Travere Therapeutics (TVTX) is engaged in a fierce struggle within the orphan nephrology segment, where leadership determines capital survival. High patient loyalty amid a shortage of alternatives ensures stability. Efficient cold chain logistics guarantee the therapy's margins and reliability. The leverage ratio reflects the dynamics of liability refinancing, while 0.60 captures the current value of the indicator.

TVTX: Travere Therapeutics Company Debts 07/04/2022 - 11/01/2026

Travere Therapeutics, Inc. (TVTX) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Price Performance Chart Travere Corp|TVTX - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Retrophin|TVTX - Total Company Value
- balance sheet equity data:
Accounting Value of a Share Travere Therapeutics|TVTX - Company Book Value|Market Cap to Net Assets Ratio travere.com|TVTX - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Travere Therapeutics|TVTX - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Travere Therapeutics Inc|TVTX - Company Debts|Debts to Book Capitalization Retrophin|TVTX - Company Long-Term Debts|Short-Term Debt Volume Travere Therapeutics|Immediate Liquidity Ratio travere.com
- earnings and valuation multiples information:
TVTX - Company Net Income
Fundamental company analysis:TVTX Travere Corp
Signature product of Travere Therapeutics Inc

This metric consolidates the issuer's total liabilities, allowing for an assessment of the debt load and the risk of credit overheating over time. By analyzing the company's debt history, an investor can compare borrowing levels with the strong pricing power of Travere Therapeutics (TVTX) in the orphan drug market, which ensures a stable free cash flow for debt service.

Competing companies

ARDX (Ardelyx Corp) - Aggregate Debt Obligations|Company Aggregate Debts PROK (ProKidney Corp.)|Company Aggregate Debts akebia.com AKBA|TVRD - Company Debts|Aggregate Debt Obligations DMAC (DiaMedica Therapeutics Inc)|Unicycive (UNCY) - Company Debts|Company Total Debt rockwellmed.com|CVKD (Cadrenal Therapeutics) - Company Aggregate Debts|Company Aggregate Debts conduitpharma.com|Company Total Debt CALT (Calliditas Therapeutics)|RNLX (Renalytix Plc) - Aggregate Debt Obligations|Company Debts ZyVersa Therapeutics, Inc. ZVSA